摘要 |
The present invention refers to an in vitro method to detect pancreatic ductal adenocarcinoma and/or pancreatitis in an individual, to determine the stage or severity of said conditions in an individual, or to monitor the effect of therapy administeied to an individual with either one or both of said conditions; to screen for, identify, develop and evaluate the efficacy of compounds for the treatment of said conditions of the pancreas aimed at developing new medicinal products, as well as agents that inhibit the expression and/or activity of the DRM protein and/or the NBL1 protein, and/or the effects of said expression. |
申请人 |
PROGENIKA BIOPHARMA, S.A.;DEL AMO IRIBARREN, JOKIN;JUNQUERA SANCHEZ-VALLEJO, CORINA;OCHOA GARAY, JORGE;ESCUDERO GARCIA DE GALDEANO, PEDRO;ARGUEELLES SANCHEZ, MARIA, ELADIA;DE LOS TOYOS GONZALEZ, JUAN RAMON;SANTA CRUZ, SIMON;MARTINEZ MARTINEZ, ANTONIO;BARNEO SERRA, LUIS;ARIZ LOPEZ DE CASTRO, USUE;SIMON BUELA, LAUREANO |
发明人 |
DEL AMO IRIBARREN, JOKIN;JUNQUERA SANCHEZ-VALLEJO, CORINA;OCHOA GARAY, JORGE;ESCUDERO GARCIA DE GALDEANO, PEDRO;ARGUEELLES SANCHEZ, MARIA, ELADIA;DE LOS TOYOS GONZALEZ, JUAN RAMON;SANTA CRUZ, SIMON;MARTINEZ MARTINEZ, ANTONIO;BARNEO SERRA, LUIS;ARIZ LOPEZ DE CASTRO, USUE;SIMON BUELA, LAUREANO |